Lyra Therapeutics Files 8-K with Corporate Updates
Ticker: LYRA · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1327273
| Field | Detail |
|---|---|
| Company | Lyra Therapeutics, INC. (LYRA) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing, financials
TL;DR
Lyra Therapeutics filed an 8-K on 5/27/25 covering corporate changes and financial docs.
AI Summary
Lyra Therapeutics, Inc. filed an 8-K on May 27, 2025, reporting an amendment to its articles of incorporation, a Regulation FD disclosure, and other events. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing indicates corporate actions and disclosures by Lyra Therapeutics, Inc., which could impact investors' understanding of the company's governance and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative news or events.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- Lyra Therapeutics, Inc. (company) — Registrant
- May 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39273 (company_id) — Commission File Number
FAQ
What specific amendments were made to Lyra Therapeutics' articles of incorporation?
The filing indicates amendments to articles of incorporation but does not detail the specific changes within the provided text.
What is the nature of the Regulation FD disclosure mentioned in the filing?
The filing lists 'Regulation FD Disclosure' as an item, but the specific content of the disclosure is not detailed in the provided text.
What other events are reported in this 8-K filing?
The filing lists 'Other Events' as a category, but the specific events are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 27, 2025.
What is Lyra Therapeutics, Inc.'s fiscal year end?
Lyra Therapeutics, Inc.'s fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Lyra Therapeutics, Inc. (LYRA).